Outbreak of Neisseria meningitidis C in workers at a large food-processing plant in Brazil: challenges of controlling disease spread to the larger community.

Autor: Iser BP, Lima HC, De Moraes C, De Almeida RP, Watanabe LT, Alves SL, Lemos AP, Gorla MC, Gonçalves MG, Dos Santos DA, Sobel J

Publikováno v: Epidemiology & Infection; May2012, Vol. 140 Issue 5, p906-915, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Atypical bartonellosis in children: What do we know?

Autor: Lemos AP; Department of Infectious Diseases, Hospital Dona Estefânia, Lisbon, Portugal., Domingues R; Department of Infectious Diseases, Hospital Dona Estefânia, Lisbon, Portugal., Gouveia C; Department of Infectious Diseases, Hospital Dona Estefânia, Lisbon, Portugal., de Sousa R; Centre of Study of Vectors and Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal., Brito MJ; Department of Infectious Diseases, Hospital Dona Estefânia, Lisbon, Portugal.

Publikováno v: Journal of paediatrics and child health [J Paediatr Child Health] 2021 May; Vol. 57 (5), pp. 653-658. Date of Electronic Publication: 2020 Dec 10.

Phenotypic characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease in Brazil from 2002 to 2017.

Autor: Gorla MC; Bacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil., Brandao AP; Bacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil.; Oswaldo Cruz Institute, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, CEP 21040-900, RJ, Brazil., Pinhata JMW; Bacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil., de Moraes C; Secretariat of Health Surveillance, Ministry of Health, Esplanada dos Ministérios, Bloco G, Brasília, CEP 70058-900, DF, Brazil., Pereira G; General Coordination of Laboratories, Ministry of Health, Esplanada dos Ministérios, Bloco G, Brasília, CEP 70058-900, DF, Brazil., Lemos AP; Bacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil.

Publikováno v: Access microbiology [Access Microbiol] 2019 Dec 10; Vol. 2 (1), pp. acmi000079. Date of Electronic Publication: 2019 Dec 10 (Print Publication: 2020).

Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.

Autor: Muzzi A; GSK, Siena, Italy. Electronic address: alessandro.x.muzzi@gsk.com., Brozzi A; GSK, Siena, Italy. Electronic address: alessandro.x.brozzi@gsk.com., Serino L; GSK, Siena, Italy. Electronic address: laura.x.serino@gsk.com., Bodini M; GSK, Siena, Italy. Electronic address: margherita.x.bodini@gsk.com., Abad R; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain. Electronic address: rabad@isciii.es., Caugant D; Norwegian Institute of Public Health, Oslo, Norway. Electronic address: Dominique.Caugant@fhi.no., Comanducci M; GSK, Siena, Italy., Lemos AP; Instituto Adolfo Lutz, São Paulo, Brazil. Electronic address: ana.lemos@ial.sp.gov.br., Gorla MC; Instituto Adolfo Lutz, São Paulo, Brazil. Electronic address: maria.gorla@ial.sp.gov.br., Křížová P; National Institute of Public Health, Prague, Czech Republic. Electronic address: pavla.krizova@szu.cz., Mikula C; Austrian Agency for Health and Food Safety, Institute for Medical Microbiology and Hygiene, Graz, Austria. Electronic address: claudia.mikula@ages.at., Mulhall R; Irish Meningitis and Sepsis Reference Laboratory (IMSRL), Dublin, Ireland. Electronic address: Robert.Mulhall@cuh.ie., Nissen M; Queensland Paediatric Infectious Diseases Laboratory, Children's Health Research Centre, University of Queensland, Lady Cilento Children's Hospital South Brisbane, Queensland, Australia. Electronic address: michael.d.nissen@gsk.com., Nohynek H; National Institute for Health and Welfare (THL), Helsinki, Finland. Electronic address: hanna.nohynek@thl.fi., Simões MJ; National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal. Electronic address: M.Joao.Simoes@insa.min-saude.pt., Skoczyńska A; National Medicines Institute, Warsaw, Poland. Electronic address: skoczek@cls.edu.pl., Stefanelli P; Department of Infectious Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: paola.stefanelli@iss.it., Taha MK; Institut Pasteur, Paris, France. Electronic address: muhamed-kheir.taha@pasteur.fr., Toropainen M; National Institute for Health and Welfare (THL), Helsinki, Finland. Electronic address: maija.toropainen@thl.fi., Tzanakaki G; National Meningitis Reference Laboratory, National School of Public Health, Athens, Greece. Electronic address: gtzanakaki@esdy.edu.gr., Vadivelu-Pechai K; GSK, Rockville, USA. Electronic address: kumaran.k.vadivelu-pechai@gsk.com., Watson P; GSK, Rockville, USA. Electronic address: philip.s.watson@gsk.com., Vazquez JA; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain. Electronic address: jvazquez@isciii.es., Rajam G; Centers for Disease Control and Prevention, Atlanta, GA, USA., Rappuoli R; GSK, Siena, Italy. Electronic address: rino.r.rappuoli@gsk.com., Borrow R; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK. Electronic address: Ray.Borrow@phe.gov.uk., Medini D; GSK, Siena, Italy. Electronic address: duccio.x.medini@gsk.com.

Publikováno v: Vaccine [Vaccine] 2019 Feb 08; Vol. 37 (7), pp. 991-1000. Date of Electronic Publication: 2019 Jan 17.